风险资本支持是否改善了披露控制和程序? 来自管理层IPO后披露的证据
Douglas Cumming1,2, Lars Helge Hass3, Linda A Myers4
1Florida Atlantic University, Boca Raton, FL USA.
概括
风险资本 (VC) 的支持加强了新上市公司的披露控制,从而减少了内部控制的弱点. 风险投资公司的披露更具信息性,表明财务报告质量更高.
科学领域:
- 企业金融公司财务
- 会计信息系统 会计信息系统
- 财务报告 财务报告 财务报告
背景情况:
- 公司管理人员的道德决策影响披露质量,影响业绩,利操纵和欺诈.
- 披露控制和程序对于新上市的公司在像萨班斯-奥克斯利法案这样的监管环境中至关重要.
研究的目的:
- 调查风险资本 (VC) 支持对新上市公司披露控制的质量和信息性的影响.
- 确定风险投资公司的附属关系是否会影响内部控制的稳定性以及随后的财务披露的信息性.
主要方法:
- 对新上市公司的分析,将风险投资支持的公司与非风险投资支持的同行进行比较.
- 根据"萨班斯-奥克斯利法案"第302条,审查内部控制的重大缺陷.
- 评估披露的信息性,并通过随后的财务报表重新陈述来代替.
主要成果:
- 风险投资支持的公司表现出更强有力的披露控制,这可以从内部控制中较少出现重大缺陷的情况来证明.
- 风险投资支持公司的披露更具信息性,并且与后续财务报表重新陈述的可能性更高有关.
- 这表明风险投资支持的新公共实体的透明度和问责制有所提高.
结论:
- 风险资本支持与新上市公司的信息披露控制和程序的质量改善有关.
- 风险投资公司的附属性提高了财务披露的信息性,可能减少信息不对称.
- 这些发现对IPO市场的投资者,监管机构和公司治理实践产生了影响.
相关概念视频
Pharmacovigilance
866
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
866
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
137
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
137
Drug Control Governance: Regulatory Bodies and Their Impact
170
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
170
Types of Reports II: Incident or Occurrence Report
843
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
843
Legal Guidelines for Documentation
1.3K
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
1.3K
Decision Making: P-value Method
5.4K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.4K


